Applications of Orotic Acid Monohydrate in Industrial Manufacturing

As the original producer of Orotic Acid Monohydrate, we prioritize material traceability and process consistency to ensure end-use performance in complex chemical manufacturing. The following scenarios reflect major downstream industrial applications, each with detailed regulatory, technical, and process guidance for professional use.

1. Active Pharmaceutical Ingredient (API) Intermediate in Pyrimidine Synthesis

Orotic Acid Monohydrate functions as a critical intermediate for nucleotide and pyrimidine base synthesis, supporting cGMP-compliant API production for pharmaceutical use. Industrial users rely on its nucleophilic reactivity and high purity profile to deliver consistent yields across multi-step processes involving cytidine, uridine, and fluorinated pyrimidines. Production lines operate under validated batch protocols, maintaining traceability and impurity control from raw acid procurement through downstream purification and crystallization.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• USP–NF and Ph. Eur. Monographs
• 21 CFR Part 211 (US FDA)
• Chinese Pharmacopoeia production guidelines

Typical usage ratio

• Reaction ratios depend on synthetized base; generally 1.0–1.2 molar equivalents per target nucleoside, adjusted for pathway yield and process efficiency.

Downstream process integration

• Introduced at the initial condensation stage with amino compounds or halogenated sugars, prior to ring closure and downstream hydrolysis.
• Maintains defined moisture content to ensure controlled reactivity in closed systems.

Final product types

• Cytidine-based antiviral API
• Uridine analogs for neurology
• 5-Fluorouracil for oncology APIs
• Precision nucleoside building blocks for custom synthesis

2. Livestock Feed Additive for Nutritional Fortification

Industrial feed manufacturers use orotic acid monohydrate to enhance ruminant nutrition and growth performance by improving pyrimidine metabolism, micronutrient assimilation, and cellular development in livestock. Blenders and premix producers introduce it through controlled batch addition, meeting national and regional additive regulations to guarantee animal safety and defined residue characteristics for the food chain.

Industry compliance standards

• EU Regulation (EC) No 1831/2003 on feed additives
• US FDA Food Additive Status List (21 CFR 573.940)
• ISO 22000 Animal Feed Safety Management
• China Ministry of Agriculture GB/T animal feed standards

Typical usage ratio

• 0.01–0.1% by weight in total compound feed, dependent on target species, feed intake levels, and veterinary guidance.

Downstream process integration

• Added during dry mixing before pelleting or extrusion to preserve acid stability.
• Process monitored for uniform distribution and absence of overheating.

Final product types

• Complete cow and calf compound feed
• High-protein sheep and goat blends
• Custom micronutrient cattle premixes
• Performance swine nutrition pellets

3. Nutritional Supplement Ingredient for Human Health Products

Health supplement manufacturers incorporate orotic acid monohydrate as a source of bioavailable pyrimidine for cognitive and metabolic support. Its role as a mineral chelator in calcium orotate formulations is well-established, requiring rigorous assessment of purity, trace heavy metals, and batch consistency. Manufacturing under HACCP and ISO 22000 ensures safety and compliance for global finished product markets.

Industry compliance standards

• US FDA 21 CFR 111 (Dietary Supplement GMP)
• European Directive 2002/46/EC on Food Supplements
• HACCP and ISO 22000 quality management
• China National Food Safety Standard GB 31601

Typical usage ratio

• Standard tablet or capsule dosage: 250–1,000 mg per daily consumption unit, based on regulatory maximums and formulation matrix; bulk blends adjusted accordingly.

Downstream process integration

• Direct mixing with excipients prior to granulation and tabletting or encapsulation.
• Mineral complexes formed via in situ reaction with selected salts under defined pH and moisture conditions.

Final product types

• Calcium orotate and magnesium orotate dietary supplements
• Multi-nutrient wellness tablets
• Sports performance capsules
• Specialty cognitive support supplement lines

4. Laboratory Reagent for Molecular and Biochemical Research

Research institutions and chemical synthesis companies deploy orotic acid monohydrate as a substrate or analytical standard in metabolic pathway tracing, enzyme activity assays, and controlled biosynthetic experiments. The material’s stability and defined hydration level permit high-precision work, while batch records and CoA documentation satisfy procurement requirements under leading institutional quality systems.

Industry compliance standards

• ISO 9001 certified production and documentation
• GLP (Good Laboratory Practice) for reagent quality
• OECD Principles of Good Laboratory Practice
• Traceability to USP/Ph. Eur. reference standards for analytical use

Typical usage ratio

• Typical stock solutions: 1–10 mM in aqueous buffer for cell culture or enzymology; mass input based on molar requirements in target assay.

Downstream process integration

• Dissolved as a reference reagent into buffer systems for nucleotide synthesis pathway studies.
• Used as a calibration standard in metabolic monitoring and high-throughput screening systems.

Final product types

• Metabolic pathway assay kits
• Enzyme function screening panels
• High-purity reference substance for academic and industrial laboratories
• Custom analytical reagents for biotechnology

5. Specialty Chemical Synthesis for Fine Chemical Manufacturing

Chemical manufacturers utilize orotic acid monohydrate in the construction of heterocyclic intermediates for agrochemicals, APIs, and specialty materials. Its chemical properties, particularly in controlled hydrolysis and functional group manipulation, offer versatility for downstream alkylation, carboxylation, and halogenation reactions. Our plant delivers consistent particle size and detailed batch analytics to streamline integration in automated synthesis routes.

Industry compliance standards

• Responsible Care® Management System
• ISO 9001:2015 manufacturing quality
• REACH Regulation (EC) No 1907/2006 for chemical handling
• GHS classification and documentation for international shipment

Typical usage ratio

• Applied at 0.5–3.0 molar equivalents per desired intermediate, adjusted according to target functionality and side reaction profile.

Downstream process integration

• Charged as a crystalline solid at primary synthesis stage or in stepwise continuous-flow reactors.
• Batch records document reaction partners and pressure/temperature ranges for process validation.

Final product types

• Semi-synthetic agrochemical pesticide intermediates
• Fluorinated and metallated heterocycles
• Pharmaceutical fine chemical building blocks
• Research-grade monomers for specialty polymers